In: drug delivery systems

María José Alonso’s Lab participates in the ONCOLIBERIX Consortium for the development of oncological drugs of marine origin
December 2, 2022

This consortium, led by PharmaMar, brings together four leading research groups in nanotechnology and oncology.

Read More